Skip to content

ISGD Clinical Trials Summit 2026

November 13-15, 2026
Galveston, Texas

Pathways To Progress

 

ISGD-ClinicalTrials-Logo-2026-Final

Welcome to the Inaugural ISGD Clinical Trials Summit

Dear Colleagues and Friends,

It is a great pleasure to welcome you to Galveston for the inaugural ISGD Clinical Trials Summit 2026. This meeting marks an important new step for ISGD and our rare kidney disease community. The Clinical Trials Summit was created not simply as another scientific congress, but as a collaborative action oriented working meeting: focused, interactive, and designed around one central question, how can we make clinical trials in glomerular diseases better, faster, more informative, and ultimately more successful for our patients.

Glomerular medicine is entering an extraordinary period. Our biological understanding of disease is rapidly deepening; new biomarkers and molecular endotypes are emerging; entirely new therapeutic modalities are entering the field; and an unprecedented number of clinical development programs are underway. Yet scientific opportunity alone does not guarantee therapeutic progress. Trial design, endpoints, recruitment, site performance, regulatory pathways, operational execution, and meaningful collaboration remain most critical and often limiting steps between discovery and better care. This is why we wanted to bring the entire clinical trials community together. Over these three days, academic investigators, clinicians, trialists, regulators, industry partners, patients and patient advocates, clinical research teams, and healthcare leaders will meet not in parallel silos, but in one shared forum. We will examine where glomerular disease trials stand today, better understand each stakeholders’ pain points, learn from past successes and failures, discuss evolving biomarkers and treatment targets, explore regulatory advances, and confront the practical barriers that determine whether trials succeed in the real world. Importantly, the format is built around discussion rather than presentation alone. Different “voices” of our clinical trials community are intended to create the kind of open exchange from which concrete solutions and new collaborations can emerge. Our ambition is that participants leave Galveston not only with new knowledge, but with new partners, new ideas, and actionable pathways forward.

For ISGD, this Summit reflects what our Society aims to be: a truly collaborative international community connecting science, clinical medicine, and therapeutic development, and most importantly - getting things done!

I am particularly grateful to our partners at the University of Texas Medical Branch, to our local hosts and organizing team, to our Program Advisory Committee, our faculty, sponsors, and everyone who has helped build this inaugural meeting from an idea into reality.

Most importantly, thank you for being here at the beginning.

The Clinical Trials Summit is intended to grow into a durable platform for our field and I invite all of you to contribute openly, challenge assumptions, build bridges across traditional boundaries, and use these days together to move glomerular clinical trials forward.

Welcome to Galveston. Welcome to the inaugural ISGD Clinical Trials Summit and to our shared pathways to progress.

Tobias B. Huber, MD
President, International Society of Glomerular Disease

Barbara S. Gillespie, MD, MMS
Chief Medical and Strategic Officer, International Society of Glomerular Disease

Montrez Lucas, LMSW
Director, Strategic Operations and Events, International Society of Glomerular Disease

Agenda Highlights UPDATED TEXT 7may26 (1)

UNITING VISION, SCIENCE, AND PARTNERSHIP TO ACCELERATE KIDNEY CURES

Join us for the inaugural ISGD Clinical Trials Summit from November 13–15, 2026, in Galveston, Texas. Hosted in partnership with the University of Texas Medical Branch (UTMB), this first-of-its-kind event unites patients, nephrologists, regulators, and industry leaders to tackle glomerular disease trial challenges and accelerate the development and approval of new therapies.

Through conversations spanning early planning, strategic design, operational excellence, and rapid trial execution, this Summit is designed for those who don’t just talk about progress but actively create it—where ideas sharpen, collaborations strengthen, and breakthroughs move closer to reality. Set along the Gulf Coast, Galveston offers an inspiring backdrop where conversations flow more easily and ideas stretch further. Register today to secure your spot!

SPONSORSHIP OPPORTUNITIES

Join us in shaping the future of kidney clinical trials—your partnership will enable the Summit to deliver unique networking, professional development, and educational opportunities, while directly supporting the transformation of breakthrough science into improved patient outcomes.

Please reach out to us at: info@is-gd.org if you are interested in becoming a sponsor for our Clinical Trials Summit so that we can share the prospectus and different tiers of benefits. Thank you in advance for supporting our inaugural meeting, where we discuss any and everything related to the success of GD trials! 

SEE YOU IN GALVESTON!

01
Days